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Protocol
AbstrACt
Introduction Musculoskeletal disorders and cognitive 
diseases are prevalent, and they are significant determinants 
of morbidity and mortality in older adults. The aim of this 
study is to investigate the prevalence of musculoskeletal and 
cognitive diseases and their risk factors and also to assess 
their associations during future follow-ups.
Methods and analysis Bushehr Elderly Health (BEH) 
programme is a population-based prospective cohort study 
being conducted in Bushehr, a southern province of Iran. A 
total of 3000 older people aged ≥60 years participated in 
the first stage from which 2772 were eligible to participate 
in the second stage, which started after 2.5 years. Data 
including demographic status, lifestyle factors, general 
healthandmedical history, and mentalandfunctional health are 
collected through a questionnaire. Anthropometric measures, 
performance testsandmuscle strength, blood pressure and 
and body composition measurements are done. A total 25 
cc venous blood is taken, and sera are stored at –80°C for 
possible future analyses.
Ethics and dissemination The study protocol was approved 
by the ethics committee of Endocrinology and Metabolism 
Research Institute, affiliated to Tehran University of Medical 
Science as well as the Research Ethics Committee of Bushehr 
University of Medical Sciences. A written informed consent 
was signed by all the participants. The study findings will 
show the prevalence of musculoskeletal disease, cognitive 
impairment and their risk factors in an elderly population. The 
participants will be followed during the study to measure the 
occurrence outcomes. This study will also have the potential 
to inform the development of beneficial interventions to 
improve the management of musculoskeletal and cognitive 
impairment in Iran and other countries in the Middle East. Our 
findings will be disseminated via scientific publication as 
well as presentation to stakeholders, including the patients, 
clinicians, the public and policymakers, via appropriate 
avenues.
IntroduCtIon
The world population is ageing at an unprec-
edented rate.1 As in most other countries, the 
proportion of those 60 years and older in Iran 
was about 8.2% in 2011 and is expected to 
rise to 10% in 2020.2 The rise in the number 
of older people highlights the surging need 
for understanding the impacts and conse-
quences of this population growth as well as 
the necessity to conduct research on devel-
oping prevention and management strategies 
for non-communicable diseases (NCDs). 
Also, to avoid the socioeconomic burden 
and medical costs, more new effective 
programmes should be explored. Therefore, 
health and independence of the elderly have 
become one of the main priorities of public 
health systems.3 In addition, disability is also 
emerging as an important factor in public 
health in the world. Many comorbidities 
occurring with ageing have a great effect on 
disability. Musculoskeletal disorders are prev-
alent, and they are significant determinants 
of morbidity and mortality in older adults. 
Osteoporosis, characterised by low bone 
mass and microarchitectural deterioration 
of bone structure, should be considered as 
strengths and limitations of this study
 ► This is the large sample prospective cohort study 
in Iran focusing on musculoskeletal disorders and 
cognitive impairment in the elderly as a growing 
population.
 ► Future follow-ups in this study will allow for the 
assessment of many relevant outcomes.
 ► Collection of the DNA resource for supporting 
genetic studies in this study will be sought genes 
associated with musculoskeletal disorders and 
cognitive impairment.
 ► The participation rate in this study is high; however, 
those participants with inadequate physical ability 
and those elderly living in nursing homes are 
excluded.
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the most common bone disease. This disease may lead 
to an increase risk of fragility fractures at the wrist, hip 
and spine.4 Considering the increasing life expectancy, 
the prevalence of osteoporosis is rising dramatically. 
According to the International Osteoporosis Foundation 
estimation, currently 200 million women from different 
parts of the world suffer from the disabling disease.5 A 
meta-analysis study have revealed a high prevalence of 
osteoporosis (12% of males and 19% of females) and 
osteopenia (33% of males and 40% of females) in Iranian 
population,6 adding that some two million of them are 
at risk of experiencing osteoporosis-related fracture.7
Another musculoskeletal disorder is sarcopenia, 
the age-related decline in muscle mass and function.8 
Decline of muscle mass is started after the age of 50 and 
an annual loss of muscle mass has been reported to be 
approximately 1%–2%.9 Sarcopenia is a major risk factor 
of falling, functional limitation and disability in the 
elderly.10 Functional impairment and physical disability 
in sarcopenic people are two to three times more likely.11 
Approximately one-third of American women and 
two-thirds of American men over 60 years suffer from 
sarcopenia.12 Disability and loss of independence, falls 
and fractures are the important complications of osteopo-
rosis and sarcopenia. Therefore, researchers regard such 
conditions as ‘dysmobility syndrome’.13 In addition, other 
diseases such as metabolic syndrome, cardiovascular and 
respiratory diseases are associated with sarcopenia.14 15 So, 
the economic burden of sarcopenia is very heavy. Health-
care costs attributable to sarcopenia in the USA in 2000 
were estimated at $18.5 billion.11
Other important age-related health problems are 
dementia and cognitive disorders. The incidence of 
dementia rises with age and can impose a great health 
and social burden on ageing people. It is estimated that 
35.6 million people are living with dementia now and that 
the number will reach 115.4 million in 2050. In 2010, 
57.7% of people with dementia live in developing coun-
tries, and this is predicted to increase to 70.5% by 2050.16 
Because dementia is a major cause of disability, it is very 
important to identify signs and symptoms of dementia at 
the early stages in order to reduce risk of progressing to 
an advanced disease and impaired cognitive health. In 
addition, its significance is likely to increase more than 
ever keeping in mind that more effective medical treat-
ments are designed and developed to slow the disease 
process. A subjective memory assessment could poten-
tially be informative of early signs of these diseases, 
because memory is known to be affected in preclinical 
dementia and Alzheimer’s diseases. Subjective memory 
impairments have consistently been related to depressive 
symptoms.17 18 Nevertheless, studies have indicated that 
subjective memory impairment is predictive of incident 
dementia.19 The risk factors of cognitive impairment and 
their effect sizes were not recognised yet. However, in the 
eastern Mediterranean region, there are few prospective 
studies that have assessed the risk factors of neurocogni-
tive disorders.
Depression is the most frequent mental health problem 
in the elder population and by the year 2020 has reached 
the second place in Disability-Adjusted life year(DA-
LY’s) ranking.20 It is a risk factor for other diseases like 
dementia and hospitalisation.21 The prevalence of depres-
sion in later life is uncertain, which partly is due to the 
lack of diagnostic criteria for the elderly. WHO estimates 
that the prevalence of this disorder in the elderly popula-
tion varies between 10% and 20% depending on cultural 
situations.22
Given the importance of geriatric diseases, several 
elderly cohort studies are being conducted in developed 
countries.23–25 In the Middle East, there are a few large 
longitudinal studies with elderly populations.26 Bushehr 
Elderly Health (BEH) programme is a population-based 
prospective cohort study is being conducted in Bushehr, 
a southern province of Iran. The main aim of its first 
stage was to investigate the prevalence of cardiovas-
cular risk factors and their association to major adverse 
cardiovascular outcomes.27 In this stage, the study has 
been designed and implemented to determine the preva-
lence of musculoskeletal disorders, cognitive impairment 
and their risk factors, as well as investigation of falling, 
fractures, dementia, poor mobility and functional 
dependence in each follow- up assessment. Also, we will 
investigate a number of possible molecular mechanisms 
linking to geriatric diseases.
bEH progrAMME
Study design
The methodology of the BEH programme is previously 
described elsewhere,27 and here, its summary and the 
methods related to the current phase are explained. The 
BEH programme is a prospective cohort study aimed at 
investigating the prevalence of NCDs and its associated 
risk factors. Baseline measurements of the first stage 
were implemented from March 2013 to October 2014. 
The second stage has begun from October 2015, and 
data recollection is designed to be in 2.5-year intervals.
Four objectives relating to musculoskeletal disorders 
and cognitive impairment are identified as follows:
 ► to determine the prevalence dementia and cognitive 
impairment and their risk factors among elderly Ira-
nians and assessment of associations with their out-
comes during future follow-ups
 ► to estimate the prevalence musculoskeletal disorders 
(osteoporosis and sarcopenia) and the risk factors 
among elderly people and assessment of associations 
with their outcomes during future follow-ups
 ► to establish a uniform database for performing subse-
quent studies of the natural history of musculoskeletal 
disorders and cognitive impairment for planning and 
evaluating interventions
 ► to collect the DNA resource for supporting genetic 
studies that have sought genes associated with muscu-
loskeletal disorders and cognitive impairment.
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The study also aims to act as a core resource and 
provides a framework to support specific substudies about 
healthy ageing at the national and international levels.
study population
The target population of this cohort study was all partic-
ipants aged 60 years residing in the city of Bushehr, the 
centre of a southern province of Iran. Based on the 
information available from the Bushehr District Health 
Centre, this population was estimated to be around 10 
000. A total of 3000 individuals were selected using a 
multistage cluster random sampling method in the first 
stage of sampling 2.5 years prior to the beginning of the 
second stage.
This sample size is enough for estimation of dementia 
prevalence with a rate of 8% ((6.5%–9%)%) and with a 
calculated power of 83% STATA (Release V.12).28
The participants had been selected from 75 neigh-
bourhoods defined by the municipality. The number 
of participants recruited from each neighbourhood was 
proportional to the number of households reported 
from the last census (about 2 years prior to the stage I). 
The participation rate for the first stage was about 91%. 
The participants and an accompanied person (usually 
a relative) signed the informed consent. None of those 
who came to the recruiting centre declined to sign the 
form.
Older people who were in care homes were excluded 
from the study. Details of inclusion and exclusion criteria 
have been described previously,27 and figure 1 shows the 
flow chart of enrolments in stage II.
outcome measurements
Every participant will be followed up for any medical 
event (fracture, falling and death) annually by telephone 
call. Each participant has been asked for any medical 
conditions by a trained nurse and, if necessary, a trained 
physician will investigate their hospital records. In the 
case of mortality, data are collected from hospital or death 
certificate by local physicians and are verified by death 
registry system in the district health centre. The collected 
data are then evaluated by an outcome committee 
consisted of principal investigator, internist, endocrinolo-
gist, epidemiologist and physician who collected outcome 
data.
data collection
In order to collect the necessary data, a questionnaire was 
developed by expert groups and was tested in a pilot study 
to identify problems with the parts and to estimate their 
time of administration. The majority of questions were 
taken from previous validated questionnaires.29–32
All participants invited to the BEH programme unit were 
referred to trained nurses, after signing informed written 
consent. The participants are interviewed by trained 
nurses to complete a 162-item questionnaire regarding 
sociodemographic data, lifestyle factors, general health 
and medical history, mental and functional health, and 
medication use. Table 1 presents the parts of the core 
questionnaire.
Physical activity level in 24 hours of sports, work and 
leisure time on an average weekday is assessed using a 
valid self-report questionnaire,33 and the intensity of every 
specific activity is expressed in metabolic equivalents. This 
instrument has been validated and used for elderlies34–36 
and also, it has been validated among Iranian adolescents 
for Farsi language.32
Dietary assessment is performed by a 24-hour dietary 
recall to obtain detailed information about all foods 
and beverages consumed in the past 24 hours. The total 
amount of each specific food and beverage consumed is 
captured by expert nutritionist. Standard reference tables 
Figure 1 Flow chart of enrolments in stage II.
Table 1 Section and topics of the questionnaire in the 
Bushehr Elderly Health programme study (stage II)
Type of data Parts
Demographic data Personal information
National identification number
Age/sex
Marital status
Contact information
Lifestyle factors Smoking (current and history)
Alcohol consumption
Drug abuse
Physical activity
Nutritional assessment
General health and 
medical history
Quality of life
Medical history
Musculoskeletal status (current 
and history)
Women’s health
Mental and functional 
Health
Cognitive function
Depression
Functional assessment
Activities of daily living
Medication use Administrated by physician
Over-the-counter drugs
Supplements
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are used to convert household portions to grams. Data 
are entered into the nutritionist IV package, modified 
for Iranian foods to obtain daily energy, nutrient intakes 
and servings of foods consumed. For mixed dishes, food 
groups and nutrients are calculated according to their 
ingredients.
Also, for evaluating the risk of malnutrition in elderly 
people, we use the Mini Nutritional Assessment. This 
practical assessment tool contains: anthropometric 
measurements, global assessment, dietary questionnaire 
and a subjective assessment that enables a subject to be 
categorised as normal (adequate nutrition), borderline 
(at risk of malnutrition) or undernutrition.37
Mental and functional health assessments are 
performed by using the MMSE, Mini-Cog, functional 
assessment staging test (FAST), the 12-item Short Form 
Health Survey (SF-12), the Patient Health Question-
naire-9 (PHQ-9), activities of daily living (ADL) and 
instrumental activities of daily living (IADL) for all partic-
ipants. They have already been validated and translated 
for use in primary care in Iran29 30 38 39 :
 ► MMSE: a brief quantitative tool that can be used to 
assess mental status in adults. It is sensitive to screen 
for cognitive impairment, to estimate the severity of 
disease, to identify early changes of cognitive status 
and to evaluate response to treatment. This tool is an 
11-question measure that tests five areas of cognitive 
function, including orientation, registration, atten-
tion and calculation, recall and language.40
 ► Mini-Cog test: another brief screen test for cognitive 
impairment is the Mini-Cog. It takes approximate-
ly 3 min to administer. Its components, including 
three-item recall and clock drawing are combined 
to discriminate dementia. It has minimal language 
content, which reduces cultural and educational 
bias.41
 ► FAST: the evaluation of changes in functional perfor-
mance and ADLs skills in elderly individuals, espe-
cially patient with dementia disease, is performed by 
FAST. The FAST scale is composed of seven major lev-
els of functioning (from normal adult to severe cog-
nitive decline); levels 6 and 7 are additionally divided 
into substages (11 total).42
 ► PHQ: it is a self-report version of the Primary Care 
Evaluation of Mental Disorders diagnostic instrument 
for common mental disorders.43 The PHQ-9 has the 
potential of being a dual-purpose instrument that, 
with the same nine items, can establish depressive dis-
order diagnoses as well as grade depressive symptom 
severity.44
 ► SF-12: Thehealth-related quality of life (QoL) that 
describes the degree of general physical health status 
and mental health distress, is performed by the SF-12. 
SF-12 measures eight health domains, including phys-
ical functioning, role physical, bodily pain, general 
health, vitality, social functioning, role emotional and 
mental health. It provides glimpses into mental and 
physical functioning and overall QoL.45
 ► ADLs and IADL: they are as part of an older person's 
functional assessment. ADLs are routine tasks to re-
fer to people’s daily self-care activities. ADLs include: 
eating, bathing, dressing, toileting, transferring (walk-
ing) and continence. An individual’s ability to per-
form ADLs is important for determining what type of 
long-term care (eg, nursing home care or home care) 
and coverage the individual needs.
IADLs are the complex skills needed to successfully live independent-
ly. These skills are cooking, driving, using the telephone or computer, 
shopping, keeping track of finances and managing medication. Togeth-
er, ADLs and IADLs represent the skills that usually make people able to 
manage their own life as independent adults.46
Clinical examination
Anthropometric measurements
Anthropometric measurements (Box 1) are taken 
with shoes removed and the participants wearing light 
clothing. Height and weight are measured with a fixed 
stadiometer and a digital scale according to the standard 
protocol.  A flexible, circumference measuring tape is 
used to measure waist (WC) and hip circumferences.  WC 
should be measured  at a point midway between the 
iliac crest and the lowest rib in standing position, and 
hip circumference should be measured as the maximal 
circumference over the buttocks.
Neck circumference is measured in the midway of the 
neck, between midcervical spine and mid anterior neck, 
just below, with the subjects standing upright. Upper arm 
circumference is measured at the midpoint between the 
box 1 physical examinations in bushehr Elderly Health 
programme study (stage II)
Anthropometric measures
 ► Height and weight
 ► Waist circumference
 ► Hip circumference
 ► Neck circumference
 ► Upper arm circumference
 ► Forearm circumference
 ► Mid-thigh circumference
 ► Calf circumference
performance-based tests
 ► Short physical performance battery (SPPB)
 ► Time to perform five chair stands
 ► Walking 2.44 m at usual gait speed
 ► Balance test
 ► Side-by-side standing position
 ► Full tandem position
 ► Semitandem position
 ► Walking 4.57 m at usual gait speed
Muscle strength
 ► Grip strength
blood pressure measurements
body composition measurements
 ► Fat mass
 ► Muscle mass
 ► Bone mineral density
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olecranon process and the acromion of right arm; also, 
forearm circumference measurement is done from the 
widest level while the arm is hanging freely at the side.
Midthigh circumference is measured at a midpoint 
between trochanterion (top of the thigh bone, femur) 
and tibiale laterale (top of the tibia bone) of right thigh. 
Calf circumference measurement is measured at the 
widest level while the participant is standing upright. All 
measurements are read to the nearest 0.1 cm.
Performance-based tests and muscle strength
To test muscle function, hand grip strength (muscle 
strength), 4.57-m usual gait speed (physical perfor-
mance) and the SPPB are measured.47 Handgrip strength 
is measured in both hands using a digital dynamometer, 
and each hand is measured three times. The main hand is 
first checked, after which participants are allowed to rest 
for 15 s; then, the other hand is checked. A 4.57 m walk 
at the subject’s normal pace is timed twice, and the time 
of the faster of the two walks is used for usual gait speed.
SPPB is a group of measures that combines the results 
of the gait speed, chair stand and balance tests to measure 
physical performance in older adults. To test ‘the chair 
stand’, participants are asked to keep their arms folded 
across their chest one time. If successful, participants 
were asked to stand up and sit down five times and are 
timed from the initial sitting to final standing position. 
‘Balance tests’ include full tandem, semitandem and side-
by-side stands. For each stand, the interviewer supports 
one arm while participants position their feet, asks if they 
are ready, then releases the support and begins timing. 
When 10 s have elapsed or participants move their feet, 
the timer is stopped. To test ‘gait speed’, at 2.44-metre 
usual gait speed is measured.
Blood pressure measurements
Two measurements of systolic blood pressure (SBP) and 
diastolic blood pressure (DBP) are performed using a 
standardised mercury sphygmomanometer on the right 
arm after a 15 min rest in a sitting position; the first and 
fifth Korotkoff sounds are taken as SBP and DBP, respec-
tively. The average of the two measurements is considered 
as the participant’s blood pressure.
Body composition measurements
Body composition for each participant is measured using 
dual x-ray absorptiometry (DXA, Discovery WI, Hologic, 
Bedford, Virginia, USA). This device can measure fat 
mass, muscle mass, head, trunk and extremities sepa-
rately with minimal radiation exposure. According to 
DXA results, we will calculate the appendicular skeletal 
muscle mass for each participant as the sum of upper 
and lower limb muscle mass. Also, the bone mineral 
density of the lumbar spine (L1-L4) and total hip are 
measured in a correct position. All scans are performed 
by a trained operator on the same day. The time, which 
is required for the evaluation of each person, will be 
20 min.
biochemical measurements
An overnight fasting venous blood sample is obtained for 
every participant for biochemical measurements. A total of 
25 cc of whole blood is collected by a trained nurse. Table 2 
presents laboratory tests performed at baseline and their 
methods of measurement. Sera are also separated and 
stored at –80°C for possible future analyses.
DNA will also be extracted from whole peripheral blood 
stored in EDTA tubes using standard methods for future 
genome-wide association studies and epigenome-wide 
association studies.
Table 2 Laboratory tests of Bushehr Elderly Health 
programme study (phase II)
Laboratory tests Method of measurement
CBC Automated haematology analyser, 
Medonic CA620 (Menarini Diagnostics 
Srl, Florence, Italy)
Fasting blood 
sugar
Enzymes (glucose oxidase) colorimetric 
method using a commercial kit (Pars
Azmun, Karaj, Iran)
Lipid profile
Total cholesterol
Enzymatic (CHOD-PAP) colorimetric 
method using a commercial kit (Pars 
Azmun)
LDL-C Enzymatic (CHE& CHO) colorimetric 
method using a commercial kit (Pars 
Azmun)
HDL-C Enzymatic (CHE& CHO) colorimetric 
method using a commercial kit (Pars 
Azmun)
Triglycerides Enzymatic (GPO-PAP) colorimetric 
method using a commercial kit (Pars 
Azmun)
Calcium Enzymatic colorimetric estimation with 
o-cresolphthalein complex method 
using a commercial kit (Pars Azmun)
Phosphorus Enzymatic UV method with 
phosphomolybdate using a commercial 
kit (Pars Azmun)
ALK-p Photometric method using a 
commercial kit (Pars Azmun)
Urea Enzymatic (urease) UV method using a 
commercial kit (Pars Azmun)
Creatinin Jaffe’s method, using a Commercial Kit 
(Pars Azmun)
Uric acid Colorimetry and uricase method using 
uric acid TOOS kit (Pars Azmun)
HbA1C Boranate affinity method using a 
CERA-STAT system (CERAGEM 
MEDISYS,chungcheongnam-do, Korea)
ALK-p, alkaline phosphatase; CBC, complete blood count; CHE, 
cholesterol esterase; CHO, cholesterol oxidase; CHOD-PAP, 
cholesterol oxidase phenol aminoantipyrine; GPO-PAP, glycerol-3-
phosphate oxidase phenol aminoantipyrine; HbA1C, haemoglobin 
A1C; HDL, high-density lipoprotein; LDL, low-density lipoprotein; 
UV, ultraviolet.
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stAtIstICAl AnAlysEs
All data will be analysed using SPSS (V.21) and STATA 
(Release V.12). Normality of variables would be assessed 
using visual inspection of histograms and the measures of 
skewness and kurtosis as well as Kolmogorov-Smirnov and 
Shapiro-Wilks tests. Data will be presented as means±SD, 
medians and IQR for continuously distributed variables 
and frequencies and percentages of categorical variables. 
For comparing descriptive results of the population, prev-
alence or incidence rates will be standardised based on 
country population at the same age–sex groups.
Appropriate parametric and non-parametric statis-
tical methods will be performed for data analyses. 
Student’s t-test or analysis of variance and their corre-
sponding non-parametric methods (Mann-Whitney and 
Kruskal-Wallis, respectively) will be used to compare 
continuous variables between the different groups. 
Pearson and Spearman correlation coefficients will be 
performed to assess the relationship between continuous 
variables. Pearson χ2 will be used to assess the associ-
ation of categorical variables. Risk ratio, rate ratio, OR 
and their 95% CIs will be used to show the association of 
binary outcomes and corresponding risk factors. Survival 
analysis will be used for time to event data. The survival 
rate and HR will be used to compare between groups. 
Appropriate multivariable analyses (linear regression, 
logistic regression, Poisson regression, analysis of covari-
ance methods, Cox proportional hazard models and so 
on) will be used for the purpose of investigating associa-
tions after controlling for potential confounders.
Missing data will be treated by performing appropriate 
methods, including replacing missing values with the 
mean of the observed values, the last measured values, 
sensitivity analysis of the best and worst scenarios and 
multiple imputation analyses.48
The level of p value ≤0.05 will be considered to indicate 
statistical significance.
EtHICs
The study protocol was approved by the ethics committee 
of Endocrinology and Metabolism Research Institute, 
affiliated to Tehran University of Medical Science as well 
as the Research Ethics Committee of Bushehr University 
of Medical Sciences. A written in forming consent was 
signed by all the participants, including the permission 
to use secondary data such as registration data for health 
service purposes, before enrolment in the study
strEngtHs And lIMItAtIons
There are several strengths of this study. First, this is the 
cohort study of older people for a longer follow-up time. 
Therefore, this study may assist in determining causal 
associations between predicted determinants of health 
and outcomes and could be used to obtain a multifaceted 
understanding of geriatric health over time. Also, this 
study enjoys a large sample size of elderly participants to 
assess musculoskeletal and cognitive diseases. The face-
to-face interview is useful in getting exact information, 
especially among the older people  who may not imme-
diately understand or respond to the questionnaire. 
Lastly, our multidisciplinary investigative team consists of 
experts in geriatrics, psychology, endocrinology, epidemi-
ology and genetics that may be helpful in developing a 
unique research resource for the understanding of geri-
atric health.
Attrition bias caused by selection bias as well as recall 
problems of the elderly people from the very first stage may 
be considered as the limitations of the current study. Long 
follow-up and case ascertainment problems should also 
be mentioned as other limitations. Another limitation of 
this study is to enter only those participants with adequate 
physical ability and the exclusion of those elderly living in 
nursing homes ,which has led to selection bias. The self-re-
ported physical activity scale tool has been validated in Farsi 
language only among Iranian adolescents and not especially 
in elderlies. However, it has been validated for elderlies in 
other studies.
ConClusIon
This study protocol describes the design and methods 
used in the stage II of BEH programme. In this study, we 
focused on the epidemiological characteristics of geri-
atric disorders, the relationship between socioeconomic 
factors and health and QoL in addition to elucidating 
biological risk factors of musculoskeletal and cognitive 
diseases, and assessment of associations during future 
follow ups in elderly persons in Bushehr, Iran. The 
follow-up assessments for each stage will be carried out 
every 5 years for three consecutive periods (a total of 
15 years of follow-up), in which all assessments will be 
repeated with comparable methods and modalities.
The study findings will improve our understanding of 
disease prevalence in the elderly of our country and will 
have the potential to inform the development of beneficial 
interventions to improve the management of musculoskel-
etal diseases and cognitive impairment in Iran and other 
countries in the Middle East and North Africa region.
Author affiliations
1Chronic Diseases Research Center, Endocrinology and Metabolism Population 
Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
2The Persian Gulf Tropical Medicine Research Center, Bushehr University of Medical 
Sciences, Bushehr, Iran
3Elderly Health Research Center, Endocrinology and Metabolism Population 
Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
4Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences 
Institute, Tehran University of Medical Sciences, Tehran, Iran
5Endocrinology and Metabolism Research Center, Endocrinology and Metabolism 
Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
6Osteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences 
Institute, Tehran University of Medical Sciences, Tehran, Iran
7The Persian Gulf Marine Biotechnology Research Center, The Persian Gulf 
Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, 
Bushehr, Iran
Acknowledgements The authors are grateful to the staff of both research 
centres at Bushehr University of Medical Sciences (BPUMS) and Tehran University 
 7Shafiee G, et al. BMJ Open 2017;7:e013606. doi:10.1136/bmjopen-2016-013606
Open Access
of Medical Sciences (TUMS) for their commitment to the study’s protocol and 
objectives. They are also indebted to all participants who accepted the invitation 
and patiently underwent exhausting measurements and examinations.
Contributors GS drafted the manuscript, participated in questionnaire 
development study design and staff training. AO and RH participated in the study 
design, questionnaire development and conduction and reviewed the manuscript. 
HD, FS, AR, FR, S.M.A and ZS participated in questionnaire development, study 
design and staff training and reviewed the manuscript. NM, MRA, HAM and AS 
participated in questionnaire development. IN and BL conceived the study, helped 
draft the manuscript and participated in the study design and conduction.
Competing interests None declared.
patient consent Obtained.
provenance and peer review Not commissioned; externally peer reviewed.
data sharing statement Data will be available for interested researchers upon 
their request via our website or through direct email to the executive manager AO ( 
a. ostovar@ bpums. ac. ir;  afshinostovar@ gmail. com).
open Access This is an Open Access article distributed in accordance with the 
terms of the Creative Commons Attribution (CC BY 4.0) license, which permits 
others to distribute, remix, adapt and build upon this work, for commercial use, 
provided the original work is properly cited. See: http:// creativecommons. org/ 
licenses/ by/ 4. 0/
© Article author(s) (or their employer(s) unless otherwise stated in the text of the 
article) 2017. All rights reserved. No commercial use is permitted unless otherwise 
expressly granted.
rEfErEnCEs
 1. Interesting facts about ageing. secondary interesting facts about 
ageing. 2012 http://www. who. int/ ageing/ about/ facts/ en/ index. html.
 2. Public relations and International Cooperation. Selected Findings of 
National Population and Housing Census, 2012. Tehran: Statistical 
Center of Iran, 2011:27.
 3. Hayat SA, Luben R, Keevil VL, et al. Cohort profile: A prospective 
cohort study of objective physical and cognitive capability and visual 
health in an ageing population of men and women in Norfolk (EPIC-
Norfolk 3). Int J Epidemiol 2014;43:1063–72.
 4. Larijani B, Bonjour JP, Resch H, et al. Osteoporosis in Iran, Overview 
and Management. Iranian J Publ Health 2007(supp 1):1–13.
 5. Kanis JA. Assessment of Osteoporosis at the Primary Health Care 
Level. WHO Technical Report Series. 66. UK: University of Sheffield, 
2007.
 6. Irani AD, Poorolajal J, Khalilian A, et al. Prevalence of osteoporosis in 
Iran: a meta-analysis. J Res Med Sci 2013;18:759–66.
 7. Keshtkar ALB, Satleghi M, Majidian M, et al. The incidence 
of osteoporotic hip fracture in Iran, a review. Osteoporos Int 
2010;21(Suppl 1().
 8. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European 
consensus on definition and diagnosis: report of the European 
Working Group on Sarcopenia in Older People. Age Ageing 
2010;39:412–23.
 9. Masanes F, Culla A, Navarro-Gonzalez M, et al. Prevalence of 
sarcopenia in healthy community-dwelling elderly in an urban area of 
Barcelona (Spain). J Nutr Health Aging 2012;16:184–7.
 10. Houston DK, Nicklas BJ, Zizza CA. Weighty concerns: the growing 
prevalence of obesity among older adults. J Am Diet Assoc 
2009;109:1886–95.
 11. Janssen I, Shepard DS, Katzmarzyk PT, et al. The healthcare costs of 
sarcopenia in the United States. J Am Geriatr Soc 2004;52:80–5.
 12. Thomas DR. Loss of skeletal muscle mass in aging: examining 
the relationship of starvation, sarcopenia and cachexia. Clin Nutr 
2007;26:389–99.
 13. Binkley N, Krueger D, Buehring B. What's in a name revisited: 
should osteoporosis and sarcopenia be considered components of 
"dysmobility syndrome?". Osteoporos Int 2013;24:2955–9.
 14. Chien MY, Kuo HK, Wu YT. Sarcopenia, cardiopulmonary fitness, and 
physical disability in community-dwelling elderly people. Phys Ther 
2010;90:1277–87.
 15. Chin SO, Rhee SY, Chon S, et al. Sarcopenia is independently 
associated with cardiovascular disease in older Korean adults: the 
Korea National Health and Nutrition Examination Survey (KNHANES) 
from 2009. PLoS One 2013;8:e60119.
 16. World Health Organization. Dementia: a public health priority, 
2012:1–112.
 17. Balash Y, Mordechovich M, Shabtai H, et al. Subjective memory 
complaints in elders: depression, anxiety, or cognitive decline? Acta 
Neurol Scand 2013;127:344–50.
 18. Reid M, Parkinson L, Gibson R, et al. Memory complaint 
questionnaire performed poorly as screening tool: validation against 
psychometric tests and affective measures. J Clin Epidemiol 
2012;65:199–205.
 19. Rönnlund M, Sundström A, Adolfsson R, et al. Self-Reported 
memory failures: associations with future dementia in a Population-
Based Study with Long-Term Follow-Up. J Am Geriatr Soc 
2015;63:1766–73.
 20. Reddy MS. Depression: the disorder and the burden. Indian J 
Psychol Med 2010;32:1–2.
 21. Stoppe G. [Depression in old age]. Bundesgesundheitsblatt 
Gesundheitsforschung Gesundheitsschutz  
2008;51:406–10.
 22.  World Health Organization. World Health Report; Mental Health: New 
Understanding New Hope.2001.
 23. Sharma SK, Tobin JD, Brant LJ. Factors affecting attrition 
in the Baltimore Longitudinal Study of Aging. Exp Gerontol 
1986;21:329–40.
 24. Hofman A, Grobbee DE, de Jong PT, et al. Determinants of disease 
and disability in the elderly: the Rotterdam Elderly Study. Eur J 
Epidemiol 1991;7:403–22.
 25. McDowell I, Hill G, Lindsay J. An overview of the Canadian study of 
Health and Aging. Int Psychogeriatr 2001;13(Supp 1):7–18.
 26. Hosseini SR, Cumming RG, Kheirkhah F, et al. Cohort profile: 
the Amirkola Health and Ageing Project (AHAP). Int J Epidemiol 
2014;43:1393–400.
 27. Ostovar A, Nabipour I, Larijani B, et al. Bushehr Elderly Health 
(BEH) Programme, phase I (cardiovascular system). BMJ Open 
2015;5:e009597.
 28. Sharifi F, Fakhrzadeh H, Varmaghani M, et al. Prevalence of Dementia 
and Associated Factors among Older Adults in Iran: National Elderly 
Health Survey (NEHS). Arch Iran Med 2016;19:838–44.
 29. Hassani Mehraban A, Soltanmohamadi Y, Akbarfahimi M, et al. 
Validity and reliability of the persian version of lawton instrumental 
activities of daily living scale in patients with dementia. Med J Islam 
Repub Iran 2014;28:25.
 30. Barekatain M, Walterfang M, Behdad M, et al. Validity and reliability 
of the Persian language version of the neuropsychiatry unit cognitive 
assessment tool. Dement Geriatr Cogn Disord  
2010;29:516–22.
 31. Amirkalali B, Sharifi F, Fakhrzadeh H, et al. Evaluation of the mini 
nutritional assessment in the elderly, Tehran, Iran. Public Health Nutr 
2010;13:1373–9.
 32. Kelishadi R, Famuri F, Sadeghi M. Assessment of Physical  
activity of adolescents in Isfahan. J Shahrekord Univ Med Sci 
2001;3:27–33.
 33. Aadahl M, Jørgensen T. Validation of a new self-report 
instrument for measuring physical activity. Med Sci Sports Exerc 
2003;35:1196–202.
 34. Andersen LG, Groenvold M, Jørgensen T, et al. Construct validity of a 
revised physical activity Scale and testing by cognitive interviewing. 
Scand J Public Health 2010;38:707–14.
 35. Aadahl M, Kjaer M, Kristensen JH, et al. Self-reported physical 
activity compared with maximal oxygen uptake in adults. Eur J 
Cardiovasc Prev Rehabil 2007;14:422–8.
 36. Aadahl M, Andreasen AH, Hammer-Helmich L, et al. Recent temporal 
trends in sleep duration, domain-specific sedentary behaviour and 
physical activity. A survey among 25-79-year-old Danish adults. 
Scand J Public Health 2013;41:706–11.
 37. Vellas B, Guigoz Y, Garry PJ, et al. The Mini Nutritional Assessment 
(MNA) and its use in grading the nutritional state of elderly patients. 
Nutrition 1999;15:116–22.
 38. Javadi PS, Zendehbad A, Darabi F, et al. Development and 
implementation of Persian test of Elderly for Assessment of 
Cognition and Executive function (PEACE). Electron Physician 
2015;7:1549–56.
 39. Montazeri A, Vahdaninia M, Mousavi SJ, et al. The Iranian  
version of 12-item short form Health Survey (SF-12): factor structure, 
internal consistency and construct validity. BMC Public Health 
2009;9:341.
 40. Galea M, Woodward M. Mini-Mental State Examination (MMSE). Aust 
J Physiother 2005;51:198.
 41. Borson S, Scanlan JM, Chen P, et al. The Mini-Cog as a screen for 
dementia: validation in a population-based sample. J Am Geriatr Soc 
2003;51:1451–4.
 42. Sclan SG, Reisberg B. Functional assessment staging (FAST) 
in Alzheimer's disease: reliability, validity, and ordinality. Int 
Psychogeriatr 1992;4(Suppl 1):55–69.
8 Shafiee G, et al. BMJ Open 2017;7:e013606. doi:10.1136/bmjopen-2016-013606
Open Access 
 43. Spitzer RL, Kroenke K, Linzer M, et al. Health-related  
quality of life in primary care patients with mental disorders. results 
from the PRIME-MD 1000 Study. JAMA  
1995;274:1511–7.
 44. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief 
depression severity measure. J Gen Intern Med  
2001;16:606–13.
 45. Ware J, Kosinski M, Keller SD. A 12-Item Short-Form Health survey: 
construction of scales and preliminary tests of reliability and validity. 
Med Care 1996;34:220–33.
 46. Katz S. Assessing self-maintenance: activities of daily living, 
mobility, and instrumental activities of daily living. J Am Geriatr Soc 
1983;31:721–7.
 47. Guralnik JM, Simonsick EM, Ferrucci L, et al. A short physical 
performance battery assessing lower extremity function: association 
with self-reported disability and prediction of mortality and nursing 
home admission. J Gerontol 1994;49:M85–M94.
 48. Sterne JA, White IR, Carlin JB, et al. Multiple imputation for missing 
data in epidemiological and clinical research: potential and pitfalls. 
BMJ 2009;338:b2393.
